Key Takeaways DexCom received a warning letter from the Food and Drug Administration following inspections of two of its ...
DexCom said that on Tuesday it received a warning letter from the U.S. FDA following inspections at its facilities in San ...
The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek ...
Medical Device Network on MSN2d
Analysts say Dexcom’s FDA warning unlikely to impact 2025 revenueDexcom was issued with an FDA warning letter after issues with “manufacturing processes and quality management systems.” ...
Dexcom has received a warning letter from the FDA, after the agency uncovered issues during two inspections of the continuous ...
The Trump Administration reversed course on plans to terminate the lease of a major Food and Drug Administration quality lab ...
Dublin, Feb. 25, 2025 (GLOBE NEWSWIRE) -- The "What are DHF, DMR and DHR? - The FDA Quality Systems Regulations Records Explained" training has been added to ResearchAndMarkets.com's offering.
Archimedic, a medical device development firm that provides Design, Regulatory, and Go-to-Market services to its clients, has ...
In a regulatory filing, DexCom (DXCM) disclosed that on March 4, the company received a warning letter from the U.S. FDA following inspections ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback